Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**S-Caine** is a topical local anesthetic formulation, primarily available as a eutectic mixture of **lidocaine 7% and tetracaine 7%** in cream or peel form, designed for rapid dermal anesthesia prior to minor medical, cosmetic, and dermatologic procedures. It functions by blocking voltage-gated **sodium channels** in nerve endings, preventing pain signal transmission; the eutectic formulation enhances skin penetration and onset speed compared to individual anesthetics. Developed for indications like venipuncture, non-ablative laser resurfacing, pulsed dye laser treatments, injections, tattooing, and minor surgeries, it provides effective numbing with a 20-30 minute application time, minimizing procedural discomfort while exhibiting a favorable safety profile for sensitive skin.[1][2][3][11]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on S-Caine.